Ratantray Pharmaceuticals Private Limited
About Ratantray Pharmaceuticals Private Limited
Data last updated:
Ratantray Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 21 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PTC058852. Its GSTIN is 08AAICR4735L1ZW (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjana Sharma and Prakash Chand Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 60 Bhartendu Chowk Ambabari, Jaipur, Rajasthan, India – 302039.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.62 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹6,604 (net margin -1%) and EBITDA of -₹5,844 (EBITDA margin -0.9%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ratantray Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressE – 60 Bhartendu Chowk Ambabari, Jaipur, Rajasthan, India – 302039
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Ratantray Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ratantray Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ratantray Pharmaceuticals Private Limited, buy the company report.
Financials of Ratantray Pharmaceuticals Private Limited
FY 2025 filings availableRatantray Pharmaceuticals Private Limited reported revenue of ₹6.62 Lakh (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 12% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5,844 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,604 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ratantray Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ratantray Pharmaceuticals Private Limited
Ratantray Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjana Sharma | Director | 21 Aug 2017 | 9 Years 2 Months | Current |
| Prakash Chand Jain | Director | 21 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Ratantray Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Devank Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2024) | -31.0% | Gautam Buddh Nagar, Uttar Pradesh, India | |||
| Medwave Pharmaceuticals Private Limited | ₹6.64 Lakh (FY 2020) | 36.0% | Delhi, India | |||
| Ratantray Pharmaceuticals Private Limitedthis company | ₹6.62 Lakh (FY 2025) | -₹6,604 | -1% | 12.0% | Jaipur, Rajasthan, India | |
| Venterra Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2016) | 0.0% | Pune, Maharashtra, India | |||
| Halitous Pharmaceuticals Private Limited | ₹6.58 Lakh (FY 2025) | -32.0% | Greater Noida, Uttar Pradesh, India |
To see the full peer comparison of Ratantray Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ratantray Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ratantray Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ratantray Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICR4735L1ZW | Rajasthan | Active | 27 Sep 2017 |
To see the full GST registrations and return filing status of Ratantray Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ratantray Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anjana Sharma was appointed as Director on 21 Aug 2017.
Frequently asked questions
Ratantray Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 21 August 2017 (9+ years old) and is registered under CIN U74999RJ2017PTC058852.
Ratantray Pharmaceuticals has 2 current directors:
- Anjana Sharma - Director
- Prakash Chand Jain - Director
The latest financial statements of Ratantray Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ratantray Pharmaceuticals is 08AAICR4735L1ZW, registered in Rajasthan.
The CIN (Corporate Identification Number) of Ratantray Pharmaceuticals is U74999RJ2017PTC058852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ratantray Pharmaceuticals was incorporated on 21 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Ratantray Pharmaceuticals by revenue are Devank Pharmaceuticals Private Limited, Medwave Pharmaceuticals Private Limited, Venterra Pharmaceuticals Private Limited, Halitous Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anjana Sharma was appointed as Director on 21 Aug 2017. Prakash Chand Jain was appointed as Director on 21 Aug 2017.
The registered office of Ratantray Pharmaceuticals is at E – 60 Bhartendu Chowk Ambabari, Jaipur, Rajasthan, India – 302039.
Ratantray Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Ratantray Pharmaceuticals is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
